The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
195 jobs Number of planned job losses
Announcement Date
22 April 2011
Employment effect (start)
31 May 2011
Foreseen end date
31 December 2011
Description
Takeda, the French subsidiary of the Japanese pharmaceutical group, announced its plan to cut 195 out of its 443 jobs. More precisely, the company will lay off 140 employees (115 sales representatives and 25 from the head office) and not fill 55 vacant positions. The workforce reduction is mainly due to a reduction in sales of 30% within the last four years as well as the loss of some important patent protections.
Takeda is a research-based global pharmaceutical company and the largest one in Japan and employs around 20,000 people worldwide. It is present in the French market since 1978
Eurofound (2011), Takeda France, Internal restructuring in France, factsheet number 71907, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71907.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
